- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death +12009 | Faculty of Medicine in Hradec Králové
- Dexrazoxan - the possibility of protection in patients after chemotherapy and irradiation1995 | First Faculty of Medicine
- Evaluation of the cardioprotective effect of dexrazoxane during administration of the cardiotoxic antineoplastic drug - daunorubicin1999 | Faculty of Medicine in Hradec Králové
- Efficacy of Dexrazoxane in Cardiac Protection in Pediatric Patients Treated With Anthracyclines2023 | Faculty of Physical Education and Sport
- Deferoxamine but not dexrazoxane alleviates liver injury induced by endotoxemia in rats2014 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Large-Scale Synthesis of Piperazine-2,6-dione and Its Use in the Synthesis of Dexrazoxane Analogues2016 | Faculty of Pharmacy in Hradec Králové
- Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity2012 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death2009 | Central Library of Charles University
- Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane2016 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts2012 | Faculty of Medicine in Hradec Králové
- Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Development of LC-MS/MS method for the simultaneous analysis of the cardioprotective drug dexrazoxane and its metabolite ADR-925 in isolated cardiomyocytes and cell culture medium2013 | Faculty of Pharmacy in Hradec Králové
- Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase II beta Interactions2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Hydrophilic interaction liquid chromatography in the separation of a moderately lipophilic drug from its highly polar metabolites - The cardioprotectant dexrazoxane as a model case2011 | Faculty of Pharmacy in Hradec Králové
- Interface-free capillary electrophoresis-mass spectrometry systemwith nanospray ionization-Analysis of dexrazoxane in blood plasma2016 | Faculty of Pharmacy in Hradec Králové
- Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits2005 | First Faculty of Medicine
- Effect of Sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) on chronic daunorubicin toxicity in rabbits: comparison with dexrazoxane2002 | Publication without faculty affiliation
- The effects of pyridoxal isonicotinoyl hydrazone and dexrazoxane on cardiovascular parameters in daunorubicin-induced cardiomyopathy in rabbits2002 | Publication without faculty affiliation
- Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite2017 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Cholinesterases in Dexrazoxane-treated Daunorubicin Cardiomyopathy in Rabbits1999 | Faculty of Medicine in Hradec Králové
- The effects of pyridoxal isonicotinoyl hydrazone and dexrazoxane on biochemical and haematological parameters in daunorubicin-induced cardiomyopathy in rabbits2002 | Publication without faculty affiliation
- Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo2015 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Treatment with dexrazoxane (ICRF-187) reduces Myocardial calcium overload in the experimental anthracycline-induced heart failure in rabbitsPublication without faculty affiliation
- Pharmacokinetics of the cardioprotective drug dexrazoxane and its active metabolite ADR-925 with focus on cardiomyocytes and the heart2018 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase II beta Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity2020 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats1998 | Faculty of Physical Education and Sport
- ICRP-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats.1998 | Faculty of Physical Education and Sport
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death2009 | Faculty of Pharmacy in Hradec Králové